These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8452316)

  • 1. IgE response in multiple myeloma.
    Tamir R; Barchat I; Weiss H; Pick AI
    Ann Allergy; 1993 Mar; 70(3):214-7. PubMed ID: 8452316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyclonal immunoglobulin E levels are correlated with hemoglobin values and overall survival in patients with multiple myeloma.
    Matta GM; Battaglio S; Dibello C; Napoli P; Baldi C; Ciccone G; Coscia M; Boccadoro M; Massaia M
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5348-54. PubMed ID: 17875762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal gammopathy of undetermined significance (MGUS) in patients with solid tumors: effects of chemotherapy on the monoclonal protein.
    Anagnostopoulos A; Galani E; Gika D; Sotou D; Evangelopoulou A; Dimopoulos MA
    Ann Hematol; 2004 Oct; 83(10):658-60. PubMed ID: 15278296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low IgE monoclonal gammopathy level in serum highlights 20-yr survival in a case of IgE multiple myeloma.
    Hayes MJ; Carey JL; Krauss JC; Hedstrom DL; Gulbranson RL; Keren DF
    Eur J Haematol; 2007 Apr; 78(4):353-7. PubMed ID: 17378894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of polyclonal immunoglobulin production by M-proteins shows isotype specificity.
    Wang L; Young DC
    Ann Clin Lab Sci; 2001 Jul; 31(3):274-8. PubMed ID: 11508831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia.
    Chiu W; Pullon H; Woon ST; Oei P; The R; Ameratunga R
    Pathology; 2010 Jan; 42(1):82-4. PubMed ID: 20025486
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
    Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF
    Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurologic and hematologic response to fludarabine treatment in IgM MGUS polyneuropathy.
    Niermeijer JM; Eurelings M; Lokhorst H; Franssen H; Fijnheer R; Wokke JH; Notermans NC
    Neurology; 2006 Dec; 67(11):2076-9. PubMed ID: 17159126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum IgE levels and reaginic-type skin reactions in sarcoidosis.
    Yagura T; Shimizu M; Yamamura Y; Tachibana T
    Clin Exp Immunol; 1975 Aug; 21(2):289-97. PubMed ID: 810284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients.
    Terpos E; Apperley JF; Samson D; Giles C; Crawley C; Kanfer E; Olavarria E; Goldman JM; Rahemtulla A
    Bone Marrow Transplant; 2003 Feb; 31(3):163-70. PubMed ID: 12621476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantation.
    Hovenga S; de Wolf JT; Guikema JE; Klip H; Smit JW; Smit Sibinga CT; Bos NA; Vellenga E
    Bone Marrow Transplant; 2000 Apr; 25(7):723-8. PubMed ID: 10745257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multiple myeloma (IgG-kappa) infiltrating central nervous system, lymph nodes, liver, and kidneys, and with elevation of IgE].
    Toyota S; Nakamura N; Dan K
    Rinsho Ketsueki; 2004 May; 45(5):408-10. PubMed ID: 15199753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes.
    Girlanda S; Fortis C; Belloni D; Ferrero E; Ticozzi P; Sciorati C; Tresoldi M; Vicari A; Spies T; Groh V; Caligaris-Cappio F; Ferrarini M
    Cancer Res; 2005 Aug; 65(16):7502-8. PubMed ID: 16103105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing neuropathies associated with monoclonal gammopathy of undetermined significance (MGUS): a framework consistent with classifying injuries according to fiber size.
    Fisher MA; Wilson JR
    Neurol Clin Neurophysiol; 2002; 2002(3):2-7. PubMed ID: 12028821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical value of the blood measurement of the free light chains of immunoglobulins].
    Bidet A; Marit G; Bérard AM
    Ann Biol Clin (Paris); 2008; 66(4):427-31. PubMed ID: 18725344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biclonal gammopathy in multiple myeloma: a case report.
    Bakta IM; Sutarka IN
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():544-8. PubMed ID: 10895208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q.
    Liebisch P; Eppinger S; Schöpflin C; Stehle G; Munzert G; Döhner H; Schmid M
    Haematologica; 2005 Apr; 90(4):489-93. PubMed ID: 15820944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significance.
    Kumar S; Rajkumar SV; Kyle RA; Lacy MQ; Dispenzieri A; Fonseca R; Lust JA; Gertz MA; Greipp PR; Witzig TE
    J Clin Oncol; 2005 Aug; 23(24):5668-74. PubMed ID: 16110026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance.
    Rossi F; Petrucci MT; Guffanti A; Marcheselli L; Rossi D; Callea V; Vincenzo F; De Muro M; Baraldi A; Villani O; Musto P; Bacigalupo A; Gaidano G; Avvisati G; Goldaniga M; Depaoli L; Baldini L
    Clin Cancer Res; 2009 Jul; 15(13):4439-45. PubMed ID: 19509142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B and T lymphocytic populations and subpopulations and natural killer cells (NK) in blood of patients with myeloma and with monoclonal gammopathy of undetermined significance (MGUS).
    Büchi G; Girotto M; Termine G; Gario S; Grosso E; Autino R; Zappalà C
    Pathologica; 1985; 77(1050):385-93. PubMed ID: 3879633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.